Animal Testing Dispute Splits NAS Panel

WASHINGTON—Nearly two years after it was convened, a National Academy of Sciences panel is searching desperately for the middle ground in a bitter debate about the use and treatment of laboratory animals. A minority report, rare in an NAS study, seems likely to emerge from the 15-member panel, which has heard scientific discussion give way to personal attacks in the course of its nine meetings. The latest spark stems from a Wall Street Journal editorial relating an account of an alleged co

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

The latest spark stems from a Wall Street Journal editorial relating an account of an alleged conversation between panelists Michael DeBakey, the Houston heart surgeon, and Christine Stevens, president of the Animal Welfare Institute. The June 16 editorial recounts a story told by DeBakey, who is lobbying in the media against a House bill that would ban the use of pound dogs in research, about a meeting several years ago with Stevens at a congressional hearing on lab animals.

According to DeBakey, Stevens thanked him for the role his pionnering efforts had played in the health of her husband, who has had coronary bypass surgery. DeBakey said that Stevens, whom the editorial mistakenly called Helen, "became flustered and ended the conversation" when told that much of his work was based on research with animals.

Stevens wrote to the newspaper June 20 demanding "a full retraction of the false and defamatory ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies